These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era. Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K Urol Oncol; 2021 Jan; 39(1):77.e17-77.e25. PubMed ID: 32863124 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. Tatsui CE; Suki D; Rao G; Kim SS; Salaskar A; Hatiboglu MA; Gokaslan ZL; McCutcheon IE; Rhines LD J Neurosurg Spine; 2014 Jan; 20(1):108-16. PubMed ID: 24206037 [TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment and evaluation of prognostic factors in spinal metastases of renal cell carcinoma]. Ulmar B; Catalkaya S; Naumann U; Gerstner S; Cakir B; Schmidt R; Reichel H; Huch K Z Orthop Ihre Grenzgeb; 2006; 144(1):58-67. PubMed ID: 16498562 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience. Dragomir A; Nazha S; Wood LA; Rendon RA; Finelli A; Hansen A; So AI; Kollmannsberger C; Basappa NS; Pouliot F; Soulières D; Heng DYC; Kapoor A; Tanguay S Urol Oncol; 2020 Oct; 38(10):799.e1-799.e10. PubMed ID: 32778475 [TBL] [Abstract][Full Text] [Related]
16. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833 [TBL] [Abstract][Full Text] [Related]
17. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. van der Poel HG; Roukema JA; Horenblas S; van Geel AN; Debruyne FM Eur Urol; 1999; 35(3):197-203. PubMed ID: 10072620 [TBL] [Abstract][Full Text] [Related]
18. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy. Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and meta-analysis. Zhao Y; Li J; Li C; Fan J; Liu L Int J Surg; 2017 May; 41():70-77. PubMed ID: 28351779 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma. Bandiera A; Melloni G; Freschi M; Giovanardi M; Carretta A; Borri A; Ciriaco P; Zannini P World J Surg; 2009 Jul; 33(7):1414-20. PubMed ID: 19365673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]